Prevention of Venous Thromboembolism in Patients with Hemorrhagic Stroke

REFERENCES

• Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am I Prey Med. 2010;38(4 suppl):S495–501.
   PubMed Web of Science ®Google Scholar
• Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am I Prey Med. 2010;38(4 suppl):S502–509.
   PubMed Web of Science ®Google Scholar
• Heit J. The epidemiology of venous thromboembolism in the community. Arteriosder Thromb Vasc Biol. 2008;28:370.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Deep vein thrombosis/pulmonary embolism (DVT/PE). June 8, 2012. http://www.cdc.gov/ncbddd/dvt/data.html. Last accessed October 12, 2012
   Google Scholar
• Kelly J, Rudd A, Lewis R, Coshall C, Moody A, Hunt BJ. Venous thromboembolism after acute ischemic stroke. A prospective study using magnetic resonance direct thrombus imaging. Stroke. 2004;35:2320–2325.
   PubMed Web of Science ®Google Scholar
• Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am I Cardiol. 2005;96(1 2):1731-1733.
   PubMed Web of Science ®Google Scholar
• Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am I Phys Med Rehabil. 2003; 82(5):364–369.
   PubMed Web of Science ®Google Scholar
• Institute for Clinical Systems Improvement. Health Care Guideline: Venous Thromboembolism Diagnosis and Treatment. 12th ed. January 2012. http://www.icsi.org/venous_thromboembolism/venous_thromboembolism_4.html. Accessed October 12, 2012.
   Google Scholar
• Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997;350(9094):1795–1798.
   PubMed Web of Science ®Google Scholar
• Aschwanden M, Labs KH, Jeanneret C, Gehrig A, Jaeger KA. The value of rapid D-dimer testing combined with structured clinical evaluation for the diagnosis of deep vein thrombosis. I Vasc Surg. 1999;30:929–935.
   Google Scholar
• Bernardi E, Prandoni P, Lensing AW, et al. D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study. The Multicentre Italian D-dimer Ultrasound Study Investigators Group. Br Med J. 1998;317(7165):1037–1040.
   PubMedGoogle Scholar
• Bates SM, Jaeschke R, Stevens SM, et al; American College of Chest Physicians. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e351S–418S.
   PubMed Web of Science ®Google Scholar
• Harvey RL, Roth EJ, Yarnold PR, Durham JR, Green D. The use of plasma D-dimer level as a screening test in the rehabilitation setting. Stroke. 1996;27:1516–1520.
   PubMed Web of Science ®Google Scholar
• Kelly J, Russ A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke. 2001; 32:262–267.
   PubMed Web of Science ®Google Scholar
• Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83(3):416–420.
   PubMed Web of Science ®Google Scholar
• Tenna AM, Kappadath S, Stansby G. Diagnostic tests and strategies in venous thromboembolism. Phlebology. 2012;27\(suppl 2):43–52.
   PubMed Web of Science ®Google Scholar
• Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. I Thromb Haemost. 2004;2(8): 1247–1255.
   Web of Science ®Google Scholar
• Fesmire FM, Brown MD, Espinosa JA, et al; American College of Emergency Physicians. Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected pulmonary embolism. Ann Emerg Med. 2011;57(6):628–652.e75.
   PubMed Web of Science ®Google Scholar
• Barbar S, Noventa F, Rossetto V, Ferrari A, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. I Thromb Haemost. 2010;8(11):2450–2457.
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Anderson FA Jr, Fitzgerald G, et al; IMPROVE Investigators. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140(3):706–714.
   PubMed Web of Science ®Google Scholar
• Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud. 1988;10:61–63.
   PubMedGoogle Scholar
• Decousus H, Tapson VF, Bergmann JF., et al; IMPROVE Investigators. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest. 2011;139(1):69–79.
   PubMed Web of Science ®Google Scholar
• Russo CA, Andrews RM. Hospital Stays for Stroke and Other Cerebrovascular Diseases, 2005. HCUP Statistical Brief #51. May 2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb51.jsp. Accessed September 19,2012.
   Google Scholar
• Aldrich D, Hunt DP. When can the patient with deep venous thrombosis begin to ambulate? Phys Ther. 2004;84(3):268–273.
   PubMed Web of Science ®Google Scholar
• Blättler W, Partsch H. Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis. Int Angiol. 2003;22(4):393–400.
   PubMed Web of Science ®Google Scholar
• Anderson CM, Overend TJ, Godwin J, Sealy C, Sunderji A. Ambulation after deep vein thrombosis: a systematic review. Physiother Can. 2009;61 (3):133–140.
   PubMed Web of Science ®Google Scholar
• Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2000;3:CD001484.
   Google Scholar
• CLOTS Trials Collaboration; Dennis M, Sandercock PA, Reid J, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009;373(9679):1958.
   PubMed Web of Science ®Google Scholar
• Lansberg MG, O'Donnell MJ, Khatri P, et al; American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e601S–36S.
   PubMed Web of Science ®Google Scholar
• Roberts VC, Sabri S, Beeley AH, Cotton LT. The effect of intermittently applied external pressure on the haemodynamics of the lower limb in man. Br Surg. 1972;59(3):223.
   PubMed Web of Science ®Google Scholar
• Comerota AJ, Chouhan V, Harada RN, et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg. 1997;226(3):306.
   PubMed Web of Science ®Google Scholar
• Morris RJ, Woodcock JR Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons. Ann Surg. 2010;251(3):393.
   PubMed Web of Science ®Google Scholar
• Lacut K, Bressollette L, Le Gal G, et al; VICTORIAh (Venous Intermittent Compression and Thrombosis Occurrence Related to Intra-cerebral Acute hemorrhage) Investigators. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology. 2005;65(6):865–869.
   PubMed Web of Science ®Google Scholar
• Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(14):1476.
   PubMed Web of Science ®Google Scholar
• Sherman DG, Albers GW, Bladin C., et al; PREVAIL Investigators. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet. 2007;369(9570):1347.
   PubMed Web of Science ®Google Scholar
• Hillbom M, Erila T, Sotaniemi K, Tatlisumak T, Sarna S, Kaste M. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand. 2002;106(2):84.
   PubMed Web of Science ®Google Scholar
• Diener HC, Ringelstein EB, von Kummer R, et al; PROTECT Trial Group. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial. Stroke. 2006;37(1):139.
   PubMed Web of Science ®Google Scholar
• Shorr AF, Jackson WL, Sherner JFI, Moores LK. Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a meta-analysis. Chest. 2008;133(1):149.
   PubMed Web of Science ®Google Scholar
• Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. I Neurol Neurosurg Psychiatry. 1991;54:466–467.
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. I Thromb Haemost. 2011 May;9(5):893–898.
   PubMed Web of Science ®Google Scholar
• Vergouwen MD, Roos YB, Kamphuisen PW. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury. Curr Opin Crit Care. 2008;14(2):149–155.
   PubMed Web of Science ®Google Scholar
• Ray WZ, Strom RG, Blackburn SL, Ashley WW, Sicard GA, Rich KM. Incidence of deep venous thrombosis after subarachnoid hemorrhage. I Neurosurg. 2009;110(5):1010–1014.
   PubMed Web of Science ®Google Scholar
• Vespa P; Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Deep venous thrombosis prophylaxis. Neurocrit Care. 2011;15(2):295–297.
   PubMed Web of Science ®Google Scholar
• Kalva SP, Somarouthu B, Hirsch J. Inferior vena cava filters for the cerebrovascular patient./ Neurointerv Surg. 2011;3(2):137–140.
   PubMed Web of Science ®Google Scholar
• Barton AL, Dudley NJ. Caval filter placement for pulmonary embolism in a patient with a deep vein thrombosis and primary intracerebral haemorrhage. Age Ageing. 2002;31 (2):144–146.
   PubMed Web of Science ®Google Scholar
• Brotman DJ, Jaffer AK, Hurbanek JG, Morra N. Warfarin prophylaxisandvenousthromboembolism in the first 5 days following hip and knee arthroplasty. Thromb Haemost. 2004;92(5): 1012–1017.
   PubMed Web of Science ®Google Scholar
• Nieto JA, Espada NG, Merino RG, Gonzalez TC. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials. Thromb Res. 2012;130(2):183–191.
   PubMed Web of Science ®Google Scholar
• Gómez-Outes A, Terleira-Fernandez Al, Suarez-Gea ML, Vargas-Castrillón E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. Br Med J. 2012;344:e3675.
   PubMed Web of Science ®Google Scholar
• Lassen MR, Raskob GE, Gallus AS, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med. 2009;361(6): 594–604.
   PubMed Web of Science ®Google Scholar
• Lassen MR, Raskob GE, Gallus AS, Pineo G, Chen D, Hornick P. ADVANCE-2 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010;375(9717): 807–815.
   PubMed Web of Science ®Google Scholar
• Lassen MR, Gallus AS, Raskob GE, Pineo G, Chen D., Ramirez LM; ADVANCE-3 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl I Med. 2010;363(26): 2487–2498.
   PubMed Web of Science ®Google Scholar
• Fuji T, Fujita S, Tachibana S, Kawai Y. A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty. I Thromb Haemost. 2010;8(11):2458–2468 .
   PubMed Web of Science ®Google Scholar
• Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G; American College of Chest Physicians. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e445–885.
   Google Scholar
• Collins R, Baigent C, Sandercock P, Peto R. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration. Br Med J. 1994;309(6963):1215.
   PubMed Web of Science ®Google Scholar
• Karthikeyan G, Eikelboom JW, Turpie AG, Hirsh J. Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? Br J Haematol. 2009;146(2):1.
   PubMed Web of Science ®Google Scholar
• Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355(9212):1295–1302.
   PubMed Web of Science ®Google Scholar
• Geerts WH, Bergqvist D, Pineo GF, et al; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed. Chest. 2008;133 (6 suppl):381S.
   Google Scholar
• Guyatt GH, Akl EA, Crowther M, Schünemann HJ, Gutterman DD, Zelman Lewis S; American College of Chest Physicians. Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):485–525.
   PubMedGoogle Scholar
• Viswanathan A, Rakich SM, Engel C, Snider R, Rosand J, Greenberg SM, Smith EE. Antiplatelet use after intracerebral hemorrhage. Neurology. 2006;66(2):206–209.
   PubMed Web of Science ®Google Scholar
• Li L, Sun T, Zhang P, Tian J, Yang K. Statins for primary prevention of venous thromboembolism. Cochrane Database Syst Rev. 2011;12:CD008203.
   Google Scholar
• Agarwal V, Phung OI, Tongbram V, Bhardwaj A, Coleman CI. Statin use and the prevention of venous thromboembolism: a meta-analysis. Int I Clin Pract. 2010;64(10):1375–1383.
   PubMed Web of Science ®Google Scholar
• Pai M, Evans NS, Shah SJ, Green D, Cook D, Crowther MA. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies. Thromb Res. 2011;128(5):422–430.
   PubMed Web of Science ®Google Scholar
• Glynn RJ, Danielson E, Fonseca FA, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl I Med. 2009;360(18):1851–1861.
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engll Med. 2006;355:549–559.
   PubMed Web of Science ®Google Scholar
• Gorelick PB. Statin use and intracerebral hemorrhageevidence for safety in recurrent stroke prevention? Arch Neurol. 2012;69(1):13–16.
   PubMed Web of Science ®Google Scholar
• Kelly B, Hunt BJ, Lewis RR, Rudd A. Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism? Stroke. 2003;34: 2999–3005.
   Google Scholar
• Joels CS, Sing RF, Heniford BT. Complications of inferior vena cava filters. Am Surg. 2003;69(8): 654–659.
   PubMed Web of Science ®Google Scholar